1. |
Smith LE. IGF21 and retinopathy of prematurity in the preterm infant[J]. Biol Neonate, 2005, 88:237-244.
|
2. |
Barnett JM, Mccollum GW, Fowler JA, et al. Harmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR[J].Invest Ophthalmol Vis Sci, 2007, 48:907-915.
|
3. |
Kato T, Kure T, Chang JH, et al. Diminished corneal angiogenesis ingelatinase a deficient mice[J].FEBS Lett, 2005, 508:187-190.
|
4. |
Poumaras CJ, Miller JW, Gragoudas ES, et al.Systemic hyperoxiadecreases vascular endothelial growth factor gene expression inischemic primate retina[J].Arch Ophthalmol, 2005, 115:1553-1558.
|
5. |
Tang Y, Nakada MT, Kesavan P, et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases[J]. Cancer Res, 2005, 65:3193-3199.
|
6. |
Zheng HC, Takahashi H, Murai Y, et al. Upregulated EMMPR I N/CD147 might contribute to growth and angiogenesis of gastric carcinoma:a good marker for local invasion and prognosis[J]. Br J Cancer, 2006, 95:1371-1378.
|
7. |
Schmidt R, Bultmann A, Ungerer M, et al. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells:implications in acute myocardial infarction[J]. Circulation, 2006, 113:834-841.
|
8. |
Reimers N, Zafrakas K, Assmann V, et al. Expression of extracellular matrix metalloproteinase inducer on micrometastatic and primary mammary carcinoma cells[J]. Clin Cancer Res, 2004 10:3422-3428.
|
9. |
Kathryn D, Curtin, Ian A, et al. Basigin (EMMPRIN/CD147) interacts with integin to affect cellular architecture[J]. J Cell Sci, 2005, 118:2649-2660.
|
10. |
Eliason K, Osborn J, Amsel E, et al. Incidence, progression and duration of retinopathy of prematurity in Hispanics and white non-Hispanic infants[J]. J AAPOS, 2007, 11:447-451.
|
11. |
Field D, Dorling J, Manktelow B, et al. Survival of extreme premature babies in a geographically defined population:prospective cohort study of 1994-9 compared with 2000-5[J]. BMJ, 2008, 336:1221-1223.
|
12. |
Giannantonio C, Papacci P, Molle F, et al. An epidemiological analysis of retinopathy of prematurity over ten years[J]. J Pediatr Ophthalmol Strabismus, 2008, 45:162-167.
|
13. |
Lad E, Nguyen T, Morton J, et al. Retinopathy of prematurity in the United States[J]. Br J Ophthalmol, 2008, 92:320-325.
|
14. |
迟静,马晓华,毕宏生, 等. 高氧诱导SD大鼠ROP动物模型的建立[J]. 国际眼科杂志, 2011, 11:1330-1333.
|
15. |
Akula JD, Favazza TL, Mocko JA, et al.The anatomy of the rat eye with oxygen-induced retinopathy[J].Doc Ophthalmol, 2010, 120:41-50.
|
16. |
Rabinowitz R, Katz G, Rosner M, et al. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity[J]. Graefe's Arch Clin Exp Ophthalmol, 2008, 246:843-848.
|
17. |
Rajap PM, Saxena P, Kaur J. Ocular angiogenesis:mechanisms and recent advances in therapy[J]. Adv Clin Chem, 2010, 50:103-121.
|
18. |
Rennel ES, Varey AH, Church ill AJ, et al. VEGF(121) b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo[J]. Br J Cancer, 2009, 101:1183-1193.
|
19. |
Yi WH, Wei RL, Cai JP, et al. The expression and significance of VEGF and TGF-B, in orb ital cavernous hemangioma[J]. Int J Ophthalmol, 2004, 4:247-249.
|